Neurotech International Ltd
ASX:NTI

Watchlist Manager
Neurotech International Ltd Logo
Neurotech International Ltd
ASX:NTI
Watchlist
Price: 0.014 AUD -6.67% Market Closed
Market Cap: AU$14.7m

Net Margin

-410.6%
Current
Improving
by 110.8%
vs 3-y average of -521.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-410.6%
=
Net Income
AU$-10.6m
/
Revenue
AU$2.6m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-410.6%
=
Net Income
AU$-10.6m
/
Revenue
AU$2.6m

Peer Comparison

Country Company Market Cap Net
Margin
AU
Neurotech International Ltd
ASX:NTI
14.7m AUD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
185.8B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.4B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
137.3B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.8B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.8B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.6B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.7B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.6B USD
Loading...

Market Distribution

In line with most companies in Australia
Percentile
32nd
Based on 4 004 companies
32nd percentile
-410.6%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

Neurotech International Ltd
Glance View

Market Cap
14.7m AUD
Industry
Health Care

Neurotech International Ltd. engages in the research, designing, marketing, and through third party manufacturers, production of wearable neurotechnology devices to assist with neurological conditions such as autism. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2016-11-04. The firm operates through its wholly owned, Malta-based subsidiary AAT Research Limited. The firm is focusing on neuro-protective, anti-inflammatory and neuro-modulatory activities of NTI/Dolce cannabis strains. The firm through its class II device Mente is focused on development and commercialisation of technological solutions for the screening and treatment of symptoms associated with conditions such as autism. Mente is, a home therapy that is clinically proven to increase engagement and relaxation in autistic children with elevated Delta band brain activity.

NTI Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-410.6%
=
Net Income
AU$-10.6m
/
Revenue
AU$2.6m
What is Neurotech International Ltd's current Net Margin?

The current Net Margin for Neurotech International Ltd is -410.6%, which is above its 3-year median of -521.4%.

How has Net Margin changed over time?

Over the last 3 years, Neurotech International Ltd’s Net Margin has increased from -552.9% to -410.6%. During this period, it reached a low of -1 209.4% on Dec 31, 2022 and a high of -152% on Jun 30, 2024.

Back to Top